Evidence map›Paper›PMID 28344868›Full record

ArticleOncoimmunology

Langerhans cells and NK cells cooperate in the inhibition of chemical skin carcinogenesis.

Daniela Ortner, Christoph H Tripp, Kerstin Komenda, Sandrine Dubrac, Bernhard Zelger, Martin Hermann, Wolfgang Doppler, Piotr Z Tymoszuk, Louis Boon, Björn E Clausen and 1 more

Abstract read
In one paragraph

Article in Oncoimmunology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Review
  9. Review
  10. Review
  11. Early antitumor activity of oral Langerhans cells is compromised by a carcinogen.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  12. Review
  13. Monocytes promote UV-induced epidermal carcinogenesis.European journal of immunology · 2021
    Article
  14. The Tumor Microenvironment in SCC: Mechanisms and Therapeutic Opportunities.Frontiers in cell and developmental biology · 2021
    Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. The Role of the Immune System in Cutaneous Squamous Cell Carcinoma.International journal of molecular sciences · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Daniela OrtnerDepartment of Dermatology, Venereology and Allergology, Medical University of Innsbruck , Innsbruck, Austria.
Christoph H TrippDepartment of Dermatology, Venereology and Allergology, Medical University of Innsbruck , Innsbruck, Austria.
Kerstin KomendaDepartment of Dermatology, Venereology and Allergology, Medical University of Innsbruck , Innsbruck, Austria.
Sandrine DubracDepartment of Dermatology, Venereology and Allergology, Medical University of Innsbruck , Innsbruck, Austria.
Bernhard ZelgerDepartment of Dermatology, Venereology and Allergology, Medical University of Innsbruck , Innsbruck, Austria.
Martin HermannDepartment of Anesthesiology and Intensive Care Medicine, Medical University of Innsbruck , Innsbruck, Austria.
Wolfgang DopplerSection for Medical Biochemistry, Medical University of Innsbruck , Innsbruck, Austria.
Piotr Z TymoszukDepartment of Internal Medicine VI, Infectious Diseases, Immunology, Rheumatology & Pneumology, Medical University of Innsbruck , Innsbruck, Austria.
Louis BoonBiocerus , Utrecht, the Netherlands.
Björn E ClausenInstitute for Molecular Medicine, University Medical Center of the Johannes Gutenberg-University Mainz , Mainz, Germany.
Patrizia StoitznerDepartment of Dermatology, Venereology and Allergology, Medical University of Innsbruck , Innsbruck, Austria.

Funding

Austrian Science Fund FWF P 21449Austrian Science Fund FWF P 21487Austrian Science Fund FWF P 27001Austrian Science Fund FWF P 28039Austrian Science Fund FWF T 737
6 · The paper itself

Abstract

Tissue immunosurveillance is an important mechanism to prevent cancer. Skin treatment with the carcinogen 7,12-dimethylbenz(a)anthracene (DMBA), followed by the tumor promoter 12-O-tetra-decanoyl-phorbol-13-acetate (TPA), is an established murine model for squamous cell carcinoma (SCC). However, the innate immunological events occurring during the initiation of chemical carcinogenesis with DMBA remain elusive. Here, we discovered that natural killer (NK) cells and Langerhans cells (LC) cooperate to impair this oncogenic process in murine skin. The depletion of NK cells or LC caused an accumulation of DNA-damaged, natural killer group 2D-ligand (NKG2D-L) expressing keratinocytes and accelerated tumor growth. Notably, the secretion of TNFα mainly by LC promoted the recruitment of NK cells into the epidermis. Indeed, the TNFα-induced chemokines CCL2 and CXCL10 directed NK cells to DMBA-treated epidermis. Our findings reveal a novel mechanism how innate immune cells cooperate in the inhibition of cutaneous chemical carcinogenesis.

Indexed as

Chemical carcinogenesisepidermisimmunosurveillanceLangerhans cellsNK cells

Identifiers

PMID28344868
PMCPMC5353916

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.